Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing’s Disease

Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing’s Disease

Conditions: Cushing’s Syndrome
Interventions: Procedure: Treatment of Cushing’s
Sponsors: Columbia University; New York Obesity and Nutrition Research Center
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 5, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments